Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | KYN-175 |
| Synonyms | |
| Therapy Description |
KYN-175 is an aryl hydrocarbon receptor (AHR) inhibitor that activates an anti-tumor response (NCI Thesaurus). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| KYN-175 | KYN175|KYN 175|IK175|IK-175|IK 175 | KYN-175 is an aryl hydrocarbon receptor (AHR) inhibitor that activates an anti-tumor response (NCI Thesaurus). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04200963 | Phase I | KYN-175 | KYN-175 in Patients With Advanced or Metastatic Solid Tumors and Urothelial Carcinoma | Completed | USA | 0 |